Page last updated: 2024-09-05

sorafenib and Micrometastases, Neoplasm

sorafenib has been researched along with Micrometastases, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anmarkrud, JA; Huitfeldt, HS; Line, PD; Liu, SZ; Scholz, H; Shi, JH; Wierød, L; Zhang, SJ	1

Other Studies

1 other study(ies) available for sorafenib and Micrometastases, Neoplasm

Article	Year
RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver. Journal of surgical oncology, 2013, Volume: 107, Issue:4 Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Fluorescent Antibody Technique; Hepatectomy; Hepatocytes; Humans; Immunohistochemistry; Liver Neoplasms; Liver Neoplasms, Experimental; Liver Regeneration; Molecular Targeted Therapy; Neoplasm Micrometastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; raf Kinases; Rats; Sorafenib	2013

Article

Year

RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver.

Journal of surgical oncology, 2013, Volume: 107, Issue:4

Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Fluorescent Antibody Technique; Hepatectomy; Hepatocytes; Humans; Immunohistochemistry; Liver Neoplasms; Liver Neoplasms, Experimental; Liver Regeneration; Molecular Targeted Therapy; Neoplasm Micrometastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; raf Kinases; Rats; Sorafenib

2013